跳至主要内容
临床试验/CTRI/2021/07/035028
CTRI/2021/07/035028已完成2 期

EFFECT OF AROKYAM KIT ( SIDDHA CONVALESCENCE MEDICINES) IN PATIENTS TREATED AT SRI NALLAMANI SIDDHA COVID CARE CENTER, TENKASI DISTRICT, TAMIL NADU - A CROSS SECTIONAL STUDY

District collector Tenkasi1 个研究点 分布在 1 个国家目标入组 1,409 人开始时间: 2021年7月23日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
1,409
试验地点
1
主要终点
To Prevent and reduce the post COVID 19 complications

研究概览

简要总结

The COVID 19 patients will be selected randomly and given the Arokiyam kit Consisting of Amukkura chooranam tablet and Nellikai legiyam for the period of 15 days for the prevention and reduction of post COVID 19 complications.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
12.00 Year(s) 至 85.00 Year(s)(—)
性别
All

入选标准

  • Post covid 19 convalescence treatment for the period of 15 days.

排除标准

  • below 12 yrs and above 85 yrs.
  • antenatal mothers were excluded Malignancy conditions Psychiatric groups.

结局指标

主要结局

To Prevent and reduce the post COVID 19 complications

时间窗: 15 days

次要结局

  • To Prevent and reduce the post COVID 19 complications(15 days)

研究者

发起方
District collector Tenkasi
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验